VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...

Navigating the Artificial Blood Cells MarketIn the landscape of modern medicine, few innovations hold the transformative ...

In a world increasingly shaped by scientific advancement and evolving societal norms, the realm of human reproduction has ...

Healthcare ERP Market Size and Growth Factors by 2034The global Healthcare ERP market is witnessing robust growth as ...

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid  Approval based on pivotal results showing improvements in sustained disease remission and ...

The next-generation personalized nutrition market is projected to expand at a CAGR of 15-17% between 2025 and 2030. Key ...

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...

Key Takeaways in this ArticleThe global Artificial Intelligence in Genomics market is valued at USD 785.12 million in 2024 ...

Testing Market is projected to expand from USD 5.47 billion in 2025 to USD 9.98 billion by 2035, at a CAGR of 6.2%. The Urinalysis segment is estimated to hold a 63.4% market share in 2025, while ...

The dental implantology software market is projected to expand from USD 240.6 million in 2025 to USD 402 million by 2035, ...

The global cell therapy technologies market is set to witness a growth rate of 12% in the next 5 years. Rising prevalence of ...

Key TakeawaysThe global Anxiety Disorder Treatment Market is projected to grow from USD 12.7 billion in 2024 to USD 18.1 ...